The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the trail is to evaluate the efficacy and safety of PEG-rhG-CSF in primary
prophylaxis and secondary prophylaxis of neutropenia after chemotherapy.